Imatinib and infection Patient Reports February 11, 2012

Imatinib Side Effects Report #5377109-1
Imatinib side effect was reported by a Consumer or non-health professional from UNITED STATES on June 28, 2007. Male patient, weighting 251.3 lb, was diagnosed with malignant glioma and was treated with Imatinib. After drug was administered, patient experienced the following side effects: bacteria stool identified, blood culture positive, cellulitis , clostridial infection, embolism, erythema, furuncle, muscular weakness. Imatinib dosage: 500 MG BID FOR 8 DAYS PO. During the same period patient was treated with IMATINIB MESYLATE, TEMOZOLOMIDE, FENTANYL TRANSDERMAL SYSTEM, LANTUS, PROVIGIL, TEMAZEPAM, METFORMIN. Patient was hospitalized. Patient recovered.

Imatinib Side Effects Report #5017510-9
Imatinib side effect was reported by a Health Professional from UNITED STATES on June 01, 2006. Male patient, weighting 251.3 lb, was diagnosed with malignant glioma and was treated with Imatinib. After drug was administered, patient experienced the following side effects: arthralgia, brain oedema, cellulitis , confusional state, deep vein thrombosis , faecal incontinence, hemiparesis, infection , muscular weakness. Imatinib dosage: 500MG BID FOR 8 DAYS PO. During the same period patient was treated with IMATINIB MESYLATE, TEMOZOLOMIDE, KEPPRA, ZOCOR, LEXAPRO, PROTONIX. Patient was hospitalized. Patient recovered.

Imatinib Side Effects Report #4646673-X
Imatinib side effect was reported by a Health Professional from on Apr 22, 2005. Female patient, weighting 113.5 lb, was diagnosed with glioblastoma multiforme and was treated with Imatinib. After drug was administered, patient experienced the following side effects: back pain , biopsy brain abnormal, brain oedema, encephalitis , gliosis, infection , malignant neoplasm progression, meningitis , meningoencephalitis bacterial. Imatinib dosage: 600MG PO QD. During the same period patient was treated with TEMOZOLOMIDE. Patient was hospitalized. Patient recovered.

Imatinib Side Effects Report #5031608-0
Imatinib side effect was reported by a Physician from FINLAND on June 09, 2006. Female patient, 63 years of age, weighting 136.7 lb, was diagnosed with gastrointestinal stromal tumour and was treated with Imatinib. After drug was administered, patient experienced the following side effects: c-reactive protein increased, infection , neutropenia, pyrexia. Imatinib dosage: 400 MG, QD. Patient was hospitalized. Patient recovered.


Imatinib Side Effects Report #5809374-8
Imatinib side effect was reported by a Health Professional from CZECH REPUBLIC on July 07, 2008. Female patient, 58 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: chromosomal mutation, infection . Imatinib dosage: unknown. During the same period patient was treated with DASATINIB. Patient died.

Imatinib Side Effects Report #5813749-0
Imatinib side effect was reported by a Health Professional from CZECH REPUBLIC on July 07, 2008. Female patient, 58 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: chromosome analysis abnormal, infection . Imatinib dosage: unknown. During the same period patient was treated with DASATINIB. Patient died.

Imatinib Side Effects Report #5872650-7
Imatinib side effect was reported by a Health Professional from ISRAEL on May 28, 2008. Female patient, 40 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: agranulocytosis, bone marrow failure, febrile neutropenia, infection , pyrexia, white blood cell count decreased. Imatinib dosage: 400MG/DAY. Patient was hospitalized. Patient recovered.

Imatinib Side Effects Report #5285112-5
Imatinib side effect was reported by a Physician from UNITED KINGDOM on Mar 21, 2007. Male patient, 13 years of age, weighting 110.9 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: epstein-barr virus infection, hypokalaemia, lymphoproliferative disorder, necrosis, pyrexia. Imatinib dosage: unknown. During the same period patient was treated with IMATINIB MESYLATE, IMATINIB MESYLATE, METHOTREXATE, VINCRISTINE. Patient was hospitalized. Patient recovered.

Imatinib Side Effects Report #5389846-3
Imatinib side effect was reported by a Physician from UNITED KINGDOM on July 10, 2007. Male patient, 13 years of age, weighting 110.9 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: catheter removal, epstein-barr virus infection, hypokalaemia, lymphopenia, lymphoproliferative disorder, necrosis, neutropenia, pyrexia. Imatinib dosage: unknown. During the same period patient was treated with IMATINIB MESYLATE, IMATINIB MESYLATE, METHOTREXATE, VINCRISTINE. Patient was hospitalized. Patient recovered.


Imatinib Side Effects Report #5397366-5
Imatinib side effect was reported by a Physician from UNITED KINGDOM on July 18, 2007. Male patient, 13 years of age, weighting 110.9 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Imatinib. After drug was administered, patient experienced the following side effects: catheter removal, epstein-barr virus infection, hypokalaemia, lymphopenia, lymphoproliferative disorder, necrosis, neutropenia, pyrexia. Imatinib dosage: unknown. During the same period patient was treated with IMATINIB MESYLATE, IMATINIB MESYLATE, METHOTREXATE, VINCRISTINE. Patient was hospitalized. Patient recovered.